» Articles » PMID: 6361173

Considerations for Formulating the Second-generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-reactive Types Within Groups

Overview
Journal J Infect Dis
Date 1983 Dec 1
PMID 6361173
Citations 156
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pneumococcal vaccines in China.

Wang S, Li B, Chen Q, Wang C, Wang B, Ye Q Hum Vaccin Immunother. 2025; 21(1):2460274.

PMID: 39882709 PMC: 11784646. DOI: 10.1080/21645515.2025.2460274.


Update on the evolving landscape of pneumococcal capsule types: new discoveries and way forward.

Ganaie F, Beall B, Yu J, van der Linden M, McGee L, Satzke C Clin Microbiol Rev. 2025; 38(1):e0017524.

PMID: 39878373 PMC: 11905375. DOI: 10.1128/cmr.00175-24.


Computationally Optimized Hemagglutinin Proteins Adjuvanted with Infectimune Generate Broadly Protective Antibody Responses in Mice and Ferrets.

Allen J, Zhang X, Medina J, Thomas M, Lynch A, Nelson R Vaccines (Basel). 2025; 12(12.

PMID: 39772026 PMC: 11679666. DOI: 10.3390/vaccines12121364.


Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.

Feemster K, Hausdorff W, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A Vaccines (Basel). 2024; 12(9).

PMID: 39340006 PMC: 11435891. DOI: 10.3390/vaccines12090974.


Biological puzzles solved by using : a historical review of the pneumococcal studies that have impacted medicine and shaped molecular bacteriology.

Hiller N, Orihuela C J Bacteriol. 2024; 206(6):e0005924.

PMID: 38809015 PMC: 11332154. DOI: 10.1128/jb.00059-24.